| Literature DB >> 26639916 |
Julia R Heckenast1, Lawrence S Wilkinson1, Matthew W Jones2.
Abstract
Appropriately powered genome-wide association studies combined with deep-sequencing technologies offer the prospect of real progress in revealing the complex biological underpinnings of schizophrenia and other psychiatric disorders. Meanwhile, recent developments in genome engineering, including CRISPR, constitute better tools to move forward with investigating these genetic leads. This review aims to assess how these advances can inform the development of animal models for psychiatric disease, with a focus on schizophrenia and in vivo electrophysiological circuit-level measures with high potential as disease biomarkers.Entities:
Keywords: Animal model; CRISPR; Genetics; Neurophysiology; Schizophrenia
Mesh:
Year: 2015 PMID: 26639916 DOI: 10.1016/bs.adgen.2015.09.001
Source DB: PubMed Journal: Adv Genet ISSN: 0065-2660 Impact factor: 1.944